Pivot Bio Analysis: $2.0B Raised
What is Pivot Bio?
Microbial nitrogen solutions for sustainable agriculture
Employees
201-500
Founded
2011
Valuation
$2 billion
HQ Full Address
2910 Seventh Street, Berkeley, California 94710, United States
Revenue Growth Rate
60%
Product Features & Capabilities
- PROVEN® 40 for corn
- RETURN® for wheat
- RETAIN® for sorghum
- CERT-N for cotton
- N-OVATOR® Program for emission reduction credits
Investment Focus
Pivot Bio primarily focuses on the agricultural market, specifically targeting crop production through innovative microbial nitrogen solutions. Their products are designed to optimize nitrogen delivery directly to plant roots, thereby enhancing crop yields and sustainability. They aim to transform agriculture by reducing reliance on synthetic fertilizers and improving nitrogen efficiency in farming practices.
Other Considerations
Recognized in TIME magazine's 200 Best Inventions; Over $6 million paid to farmers through N-OVATOR® since 2022; Achieved 1,050,000 metric tons of CO2e avoided since 2022
Latest Funding Round
Pivot Bio recently closed a $430 million Series D funding round on August 29, 2023. The funding was led by DCVC and Temasek, among other investors.
Awards Recognition
Pivot Bio has received several awards and recognitions in the biotech field, including:
1. Recognition as one of the "World's 50 Most Innovative Companies" by Fast Company.
2. Named to TIME's list of the "Best Inventions" for their N-OVATOR® program in 2024.
3. Included in the FoodTech 500 and THRIVE TOP50 AgTech lists in 2022.
4. Recognized by TIME for the invention of PROVEN® 40 OS in 2023.
1. Recognition as one of the "World's 50 Most Innovative Companies" by Fast Company.
2. Named to TIME's list of the "Best Inventions" for their N-OVATOR® program in 2024.
3. Included in the FoodTech 500 and THRIVE TOP50 AgTech lists in 2022.
4. Recognized by TIME for the invention of PROVEN® 40 OS in 2023.
Regulatory Approvals
Pivot Bio's products have received regulatory approvals from the USDA, FDA, and EPA in the United States. They are approved for distribution and use in 47 U.S. states, excluding Alaska, California, and Hawaii. The company emphasizes that their products are regulated in every country where they operate.
Partnerships
Pivot Bio has established several significant partnerships in the biotech industry, including:
1. A distribution partnership with MFA Incorporated, announced in January 2025, aimed at enhancing the availability of their innovative agricultural solutions.
2. A strategic distribution partnership with Hefty Seed Company, announced in December 2024, to expand their retail presence.
3. A partnership with ALCIVIA to grow their retail network, announced in February 2025.
4. Collaboration with 3Bar Biologics to address barriers to the adoption of biologicals in agriculture, focusing on nitrogen-fixing microbial products.
1. A distribution partnership with MFA Incorporated, announced in January 2025, aimed at enhancing the availability of their innovative agricultural solutions.
2. A strategic distribution partnership with Hefty Seed Company, announced in December 2024, to expand their retail presence.
3. A partnership with ALCIVIA to grow their retail network, announced in February 2025.
4. Collaboration with 3Bar Biologics to address barriers to the adoption of biologicals in agriculture, focusing on nitrogen-fixing microbial products.
Key Innovations
- PROVEN G3
- CERT-N
